BioMarin Pharmaceuticals Inc

BMRNNASDAQ • USD
57.23 USD
↗ 0.53 (0.93%)AT CLOSE (03:59 PM EST)
57.25
↗ 0.02 (0.03%)
POST MARKET (AS OF 04:14 PM EST)
Post Market
AS OF 04:14 PM EST
57.25
↗ 0.02 (0.03%)
🔴Market: CLOSED

BMRN is currently priced at $57.23. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. Key drivers include a weak Piotroski F-Score of 2/9, negative Return on Equity and a bullish Golden Cross on the moving averages. BMRN is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Nov 13, 2026.

Open?$56.86
High?$57.39
Low?$56.35
Prev. Close?$56.70
Volume?1.5M
Avg. Volume?2.5M
VWAP?$57.08
Rel. Volume?0.58x
Bid / Ask
Bid?$52.50 × 1.0K
Ask?$59.50 × 1.0K
Spread?$7.00
Midpoint?$56.00
Valuation & Ratios
Market Cap?11.1B
Shares Out?193.7M
Float?193.1M
Float %?99.7%
P/E Ratio?N/A
P/B Ratio?1.77
EPS?-$0.10
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
Employees
3.2K
Market Cap
11.1B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
1999-07-23
Address
105 DIGITAL DRIVE
NOVATO, CA 94949
Phone: (415) 506-6700
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
31
Momentum?
33
Short Sent.?
30
Piotroski F-Score?2/9Weak
Altman Z-Score?1.86Grey
Confidence?80%High
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?7.32%Elevated
Short Interest?14.1M
Days to Cover?5.8
Free Float193.1M
Avg Daily Volume2.4M
Settlement Date2026-10-30
Financial Health
Current Ratio?2.44Strong
Quick Ratio?1.32Adequate
Cash Ratio?0.46Low
Debt/Equity?0.67Moderate
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
73/100
P/E?
N/A▾
P/B?
Peers
100
S&P
81
1.77CHEAP▾
P/S?
Peers
100
S&P
50
3.03FAIR▾
P/FCF?
Peers
100
S&P
56
19.9CHEAP▾
EV/EBITDA?
Peers
100
S&P
7
38.0HIGH▾
EV/Sales?
Peers
100
S&P
47
3.97FAIR▾
Returns & Efficiency
ROE?
S&P
15
-0.3%WEAK▾
ROA?
S&P
7
-0.2%WEAK▾
Cash Flow & Enterprise
FCF?$557.9M
Enterprise Value?$14.5B
Fundamentals ratios updated end of day